Events

For the past 29 years, PharmaVentures has acted as advisor on over 900 deal related projects covering licensing, mergers, acquisitions, divestments, and joint venture activities for companies world-wide

We have unrivalled strategic insight in the commercialisation and transaction of assets and companies in the pharmaceutical, biotech, medtech and diagnostics sectors. We have been trusted by major corporations, high growth biotechs and emerging companies to provide insight and advice to help these businesses achieve their strategic goals. Operating globally in M&A, licensing, divestments and fundraising, we have the skills and experience to help you drive your business forward.

PharmaVentures attends key conferences and meetings to discuss our services and we also attend events on behalf of our clients, promoting advisory mandates in M&A and licensing across the life science sector. 

How To Meet Us

We often have opportunities that could be transformative to your business, especially with the optimal strategy and best execution.

Our team attending these events are available to speak with you about your own requirements. To book a meeting, email us at:

enquiries@pharmaventures.com

Upcoming events

6-10 December 2021 

Genesis 2021

Jessie You, Associate, and Dr Luke Lee, Associate, will be available for 1-1 meetings, digitally for the full event and in London on 9th December.

10-14 January 2022 

BIO Partnering during JPM Week

Vanessa Carle, Associate, will be available for 1-1 meetings.

17-19 January 2022 

BIOTECH SHOWCASE™

Jessie You, Associate, will be available for 1-1 meetings.

28 February 2022 

3rd Annual European HealthTech CEO Forum

PharmaVentures will be speaking this event and taking part in 1-1 meetings digitally.

1-2 March 2022 

15th Annual European Life Sciences CEO Forum

Dr Fintan Walton, CEO, will be chairing the Pharma M&A and Partnering Panel in Switzerland, when we will also be taking part in 1-1 meetings.

Recent events

9-11 November 2021 

CPhI Worldwide

Mark Andrews, Managing Director and Dr Jansen Jacob, Vice President, took part in 1-1 meetings.

15-18 November 2021 

MEDICA Trade Fair

Dr Adrian Dawkes, Managing Director, and Mark Andrews, Managing Director took part in 1-1 meetings.

25-28 October 2021 

BIO-Europe

Vanessa Carle, Associate, attended this virtual event and took part in 1-1 meetings.

11-13 October 2021 

CPhI Korea

Dr Luke Lee, Associate, attended 1-1 networking meetings.

Find out more about PharmaVentures’ Korean Market Expertise

5-8 October 2021 

Sachs HealthTech Investment and Biotech Forum

Dr Fintan Walton, Founder & CEO, chaired a session and Mark Andrews, Managing Director, participated in a panel discussion.

23 September 2021 

BioForward

Vanessa Carle, Associate, attended this  event in person.

20-23 September 2021 

BIOPHARM AMERICA

Vanessa Carle, Associate, attended 1-1 networking meetings.

15 September 2021 

N-Site Expert Advice Clinic

Dr Adrian Dawkes, Managing Director attended this virtual event and took part in 1-1 meetings.

10-12 August 2021 

CPhI North America

Mark Andrews and Dr Jansen Jacob, attended 1-1 networking meetings.

5-6 July 2021 

ON Helix Digital

Vanessa Carle, Associate, attended 1-1 networking meetings.

21-25 June 2021 

BioTrinity 2021

Dr Adrian Dawkes, Managing Director, attended 1-1 partnering meetings.

16-18 June 2021 

BIO Digital 2021

Dr Adrian Dawkes and Stephen Walterman attended 1-1 partnering meetings.

9-21 June 2021 

BIO KOREA 2021

Dr Fintan Walton & Dr Adrian Dawkes presented at BIO Korea. Find out more about PharmaVentures’ Korean Market Expertise.

19 May 2021 

BIA Start-up Festival

Mark Andrews, Managing Director chaired a panel discussion and Dr Adrian Dawkes attended 1-1 meetings.

17-19 May 2021 

BIO-Equity Europe

Mark Andrews, Managing Director attended this virtual event.

28-30 April 2021 

Sachs Neuroscience Innovation Forum 

Mark Andrews, Managing Director attended this virtual event. 

10-15 April 2021 

AACR Annual Meeting

Dr Adrian Dawkes, Managing Director, attended this virtual event.

PharmaVentures InSights:
The impact of conference cancellations on dealmaking
during the Covid-19 pandemic

Can Partnering Conference Cancellations Affect Dealmaking in 2020?

We all got used to the partnering conference circuit as a means to introduce the latest developments to potential partners. So now they are all temporarily suspended whilst we overcome the current global health challenge, how do you make sure your opportunities are still getting in front of your potential partners.

PharmaVentures has been successfully connecting buyers and sellers for over 28 years with and without partnering conferences.

PharmaVentures’ CEO, Dr. Fintan Walton talks about how PharmaVentures is continuing a business as usual approach for all of our clients.


Don’t hesitate to contact us to help you carry on dealmaking.